A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern.

ABSTRACT:

SUBMITTER: Lv P 

PROVIDER: S-EPMC9188817 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature